We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PFIZER BUPIVACAINE 0.25% w/v WITH ADRENALINE (epinephrine) 1:400,000 injection solution vial, Pfizer Australia Pty Ltd, CON-291
Product name
PFIZER BUPIVACAINE 0.25% w/v WITH ADRENALINE (epinephrine) 1:400,000 injection solution vial
Sponsor name
Pfizer Australia Pty Ltd
ARTG details
- 292525
Consent start
Consent no.
CON-291
Duration
The consent is effective from the date of this letter until further notice.
Standard
Section 10(3)(a) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines.
Non-compliance with standard
The vial labels do not list the excipients and amounts.
Conditions imposed
The product labels comply with the agreed text where the vial labels do not
list the excipients and amounts, but include the text 'Contains Sulfites'.
Import, Supply, &/or Export
Supply
Therapeutic product type
Prescription medicines